Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum β-lactamases produced by Klebsiella pneumoniae and escherichia coli isolated in hospitals in paraguay

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 6, 2009, Pages 1330-1332

  Khan, Mushtaq A ^a   Lemmens, Nicole ^a   Riera, Esteban ^b   Blonk, Tamara ^a   Goedhart, Janet ^a   Van Belkum, Alex ^a   Goessens, Wil ^a   Hays, John P ^a   Van Westreenen, Mireille ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LABORATORIO CENTRAL DE SALUD PÚBLICA   (Paraguay)

Author keywords

CTX M; Enterobacteriaceae; ESBLs; SHV; TEM

Indexed keywords

BETA LACTAMASE CTX M 2; BETA LACTAMASE CTX M 56; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLONAL VARIATION; ESCHERICHIA COLI; GENOTYPE; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; LETTER; NONHUMAN; PARAGUAY; PHENOTYPE; ARTICLE; BACTERIUM IDENTIFICATION; BIOSYNTHESIS; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PARAGUAY; PLASMIDS; POLYMERASE CHAIN REACTION;

EID: 76249091680     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp382     Document Type: Letter

References (8)

1. Villegas MV, Kattan JN, Quinteros MG et al. Prevalence of extended-spectrum b-lactamases in South America. Clin Microbiol Infect 2008; 14 Suppl 1: 154-8.
2. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64 Suppl 1: i3-10.
3. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
4. Villegas MV, Correa A, Perez F et al. Prevalence and characterization of extended-spectrum b-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis 2004; 49: 217-22.
5. Woodford N, Kaufmann ME, Karisik E et al. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England. J Antimicrob Chemother 2007; 59: 106-9.
6. Minarini LA, Climaco EC, Guimaraes DB et al. Clonal transmission of ESBL-producing Klebsiella spp. at a university hospital in Brazil. Curr Microbiol 2008; 56: 587-91.
7. Pallecchi L, Bartoloni A, Fiorelli C et al. Rapid dissemination and diversity of CTX-M extended-spectrum b-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007; 51: 2720-5.
8. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.